SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Understanding respiratory tract infections through minimally-invasive, daily nasal sampling in children

This project aims to elucidate the immune and microbiota factors influencing upper respiratory tract infections in children through innovative nasal sampling and multi-omics analyses, enhancing diagnostics and public health strategies.

Subsidie
€ 1.677.858
2023

Projectdetails

Introduction

Pneumonia is the number one infectious cause of death in children worldwide. Many of the viruses and bacteria that cause pneumonia regularly infect, or colonize, the upper respiratory tract (URT) without causing disease. This drives community transmission but is also an important source of immunity. The processes and key host immune and microbiota factors that determine the infection kinetics, transmission, and development of immunity during such infections need elucidation.

Methodology

I have recently optimized minimally-invasive nasal sampling analysis methods using Synthetic Absorptive Matrix (SAM) strips that now allow me to address these knowledge gaps. Through the daily collection of such well-tolerated nasal samples in children, I will study:

  1. Non-pathological, naturally-acquired URT infections.
  2. Controlled infections in an ethical and safe manner using the live attenuated influenza vaccine.

In addition, I will perform high-frequency nasal sampling in groups of schoolchildren to precisely measure transmission events over time and even infer exposure.

Data Collection

Incoming bacteria, viruses, and the resident URT microbiome, as well as mucosal host innate and adaptive immune responses, will be quantified in parallel throughout infections using existing and new high-throughput assays, including:

  • An antigen array.
  • Microfluidic qPCR for 32 pathogens.

Analysis

Multi-omics integrative time-series analyses and mathematical modeling will be used to identify parameters that are central and predictive for:

  1. Pathogen acquisition.
  2. Replication and clearance.
  3. Transmission and immune boosting.

Key novel markers and concepts will be validated using state-of-the-art in vitro mucosal models.

Impact

The comprehensive and detailed understanding of URT infections obtained in this project can lead to better diagnostics, mucosal targeted therapies, and vaccines. It will also provide a basis for the improved predictions of pathogen spread and public health effects of interventions at the population level.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.677.858
Totale projectbegroting€ 1.677.858

Tijdlijn

Startdatum1-7-2023
Einddatum30-6-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • ACADEMISCH ZIEKENHUIS LEIDENpenvoerder

Land(en)

Netherlands

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Dynamics and heterogeneity of early viral infection

This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.

ERC Consolid...€ 2.000.000
2023
Details

Reversing vaccine hypo-responsiveness

The project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally.

ERC Advanced...€ 2.372.681
2022
Details

Deciphering the antibody-microbiota axis in early life

This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.

ERC Starting...€ 1.650.000
2023
Details

Questioning the Epidemiology of Subclinical Tuberculosis

The TB-QUEST study aims to investigate the transmission potential of subclinical TB using genome sequencing and wearable technology, challenging current definitions and screening methods.

ERC Starting...€ 2.499.700
2024
Details

Human genetic determinants of invasive group A streptococcal host-pathogen interactions

This project aims to identify genetic factors that increase susceptibility to invasive Group A streptococcus infections by integrating human genetics with host-pathogen interaction studies.

ERC Starting...€ 1.496.978
2025
Details
ERC Consolid...

Dynamics and heterogeneity of early viral infection

This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.

ERC Consolidator Grant
€ 2.000.000
2023
Details
ERC Advanced...

Reversing vaccine hypo-responsiveness

The project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally.

ERC Advanced Grant
€ 2.372.681
2022
Details
ERC Starting...

Deciphering the antibody-microbiota axis in early life

This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.

ERC Starting Grant
€ 1.650.000
2023
Details
ERC Starting...

Questioning the Epidemiology of Subclinical Tuberculosis

The TB-QUEST study aims to investigate the transmission potential of subclinical TB using genome sequencing and wearable technology, challenging current definitions and screening methods.

ERC Starting Grant
€ 2.499.700
2024
Details
ERC Starting...

Human genetic determinants of invasive group A streptococcal host-pathogen interactions

This project aims to identify genetic factors that increase susceptibility to invasive Group A streptococcus infections by integrating human genetics with host-pathogen interaction studies.

ERC Starting Grant
€ 1.496.978
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Development and validation of a universal bacterial diagnostics test to detect the respiratory microbiome and pathogenic disturbances therein for routine microbial laboratories

Er is geen beschikbare samenvatting van het project.

Mkb-innovati...€ 149.940
2013
Details
Mkb-innovati...

Development and validation of a universal bacterial diagnostics test to detect the respiratory microbiome and pathogenic disturbances therein for routine microbial laboratories

Er is geen beschikbare samenvatting van het project.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 149.940
2013
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.